Cargando…
Are national treatment guidelines for falciparum malaria in line with WHO recommendations and is antimalarial resistance taken into consideration? – A review of guidelines in non‐endemic countries
OBJECTIVE: Plasmodium falciparum infections are a relatively rare but potentially deadly disease found in returning travellers. We compare the national treatment guidelines of non‐endemic countries with the WHO guidelines for the treatment of Plasmodium falciparum infections. METHODS: Review. We ide...
Autores principales: | Visser, Marc T., Zonneveld, Rens, Peto, Thomas J., van Vugt, Michele, Dondorp, Arjen M., van der Pluijm, Rob W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304135/ https://www.ncbi.nlm.nih.gov/pubmed/34978744 http://dx.doi.org/10.1111/tmi.13715 |
Ejemplares similares
-
Comment on Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781
por: van der Pluijm, Rob W., et al.
Publicado: (2022) -
Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
por: Tindana, Paulina, et al.
Publicado: (2021) -
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
por: Stepniewska, Kasia, et al.
Publicado: (2006) -
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
por: van der Pluijm, Rob W, et al.
Publicado: (2022) -
Plasmodium vivax Recurrence Following Falciparum and Mixed Species Malaria: Risk Factors and Effect of Antimalarial Kinetics
por: Douglas, Nicholas M., et al.
Publicado: (2011)